Research Nester published a report titled “Buprenorphine Market: Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of theglobalbuprenorphine market in terms of market segmentation by route of administration, distribution channel, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The buprenorphine market is estimated to occupy a large revenue by growing at a CAGR of ~14% during the forecast period, i.e., 2022 – 2030, owing to the rising prevalence of chronic pain disorders, increasing cases of cancer, and growing government healthcare expenditure in developed countries. Apart from these, rise in dependency of people on painkillers leading to opioid addiction is also expected to provide ample growth opportunities to the market.
The global buprenorphine market is segmented by route of administration and distribution channel. Based on route of administration, the sublingual segment is anticipated to grab the largest market share during the forecast period on the back of growing availability of buprenorphine drugs in oral dosage form. Additionally, the buccal segment is projected to witness the highest market growth in the future ascribing to the growing number of people considering oral drugs.
Grab PDF to Get More Insights and Information @ https://www.researchnester.com/sample-request-3193
Geographically, the market is segmented into five major regions, namely North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. Asia Pacific region is evaluated to witness noteworthy growth in the market during the forecast period attributing to the high patient pool and rising awareness about benefits of buprenorphine in the region. Moreover, the market in North America is assessed to occupy the largest market share in the coming years owing to the large number of cases of opioid dependency in the region.
Increasing Number of Cases of Chronic Pain Disorders to Drive Market Growth
The general population suffers from a broad range of severe chronic diseases, including cancer, pain arising from injuries and other conditions. This is giving rise to the rising usage of painkillers amongst patients. As the pain reduces, the risk to get addicted to the drugs increases. Hence, buprenorphine’s demand is estimated to grow as an anti-opioid use drug. This is considered to be a crucial factor driving market growth in the future.
However, adverse health effects related to buprenorphine is expected to operate as key restraint to the growth of the buprenorphine market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global buprenorphine market which includes company profiling of The Siegfried Group, LLP, Johnson Matthey Group, Purdue Pharma LP, Pharmaforce Inc., Hikma Pharmaceuticals PLC, Bedford Laboratories, Sun Pharmaceutical Industries Ltd., Pfizer, Inc., Neon Laboratories Ltd., Unichem Laboratories, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the buprenorphine market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Access PDF to Get More Insights and Information @ https://www.researchnester.com/sample-request-3193
About Research Nester:
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919